Slideshows Images Quizzes

Dermatop

Last reviewed on RxList: 12/15/2016
Dermatop Side Effects Center

Last reviewed on RxList 1/29/2016

Dermatop (prednicarbate emollient cream) is a topical (for the skin) steroid used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis. Dermatop cream is available in generic form. Common side effects of Dermatop cream include stinging, burning, itching, irritation, dryness, swelling, skin rash, or redness of the skin when Dermatop cream is first applied to the skin. These side effects should disappear in a few days as your body adjusts to Dermatop cream. Other side effects of Dermatop cream include thinning or softening of your skin, skin rash or irritation around your mouth, swollen hair follicles, numbness or tingling, changes in color of treated skin, blisters, pimples, crusting of treated skin, or stretch marks.

Apply a thin film dose of Dermatop Emollient Cream 0.1% to the affected skin areas twice daily. Rub in gently. It is not likely other drugs you take orally or inject will have an effect on topically applied Dermatop. But many drugs can interact with each other. Tell your doctor all prescription and over-the-counter medications and supplements you use. Dermatop should be used only when prescribed during pregnancy. It is unknown if this drug passes into breast milk when applied to the skin. Similar medications pass into breast milk when taken by mouth. Consult your doctor before breast-feeding.

Our Dermatop (prednicarbate emollient cream) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Dermatop Consumer Information

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using prednicarbate topical and call your doctor at once if you have a serious side effect such as:

  • blurred vision, or seeing halos around lights;
  • mood changes;
  • sleep problems (insomnia);
  • weight gain, puffiness in your face; or
  • muscle weakness, feeling tired.

Less serious side effects may include:

  • mild skin rash, itching, burning, swelling, or dryness;
  • thinning or softening of your skin;
  • skin rash or irritation around your mouth;
  • swollen hair follicles;
  • numbness or tingling;
  • changes in color of treated skin;
  • blisters, pimples, or crusting of treated skin; or
  • stretch marks.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Dermatop (Prednicarbate Emollient Cream)

Dermatop Professional Information

SIDE EFFECTS

In controlled adult clinical studies, the incidence of adverse reactions probably or possibly associated with the use of DERMATOP Emollient Cream (prednicarbate emollient cream) 0.1% was approximately 4%. Reported reactions included mild signs of skin atrophy in 1% of treated patients, as well as the following reactions which were reported in less than 1% of patients: pruritis, edema, paresthesia, urticaria, burning, allergic contact dermatitis and rash.

In an uncontrolled study in pediatric patients with atopic dermatitis, the incidence of adverse reactions possibly or probably associated with the use of DERMATOP Emollient Cream (prednicarbate emollient cream) 0.1 % was limited. Mild signs of atrophy developed in 5 patients (5/59, 8%) during the clinical trial, with 2 patients exhibiting more than one sign. Two patients (2/59, 3%) developed shininess, and 2 patients (2/59, 3%) developed thinness. Three patients (3/59, 5 %) were observed with mild telangiectasia. It is unknown whether prior use of topical corticosteroids was a contributing factor in the development of telangiectasia in 2 of the patients (See PRECAUTIONS, Pediatric Use.) The following additional local adverse reactions have been reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, secondary infection, striae and miliaria.

Read the entire FDA prescribing information for Dermatop (Prednicarbate Emollient Cream)

Related Resources for Dermatop

Read the Dermatop User Reviews »

© Dermatop Patient Information is supplied by Cerner Multum, Inc. and Dermatop Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors